Showing results (641-650 of 701) with videos related to

Sort By:
Pageof 71
Nature Medicine|September 1, 2024
Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomesMuthiah Vaduganathan, Gerasimos Filippatos, Brian L Claggett, et al.
Diabetes Care|November 21, 2018
Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced NephropathyJan Skupien, Adam M Smiles, Erkka Valo, et al.
Plos One|October 8, 2010
Urinary collagen fragments are significantly altered in diabetes: a link to pathophysiologyDavid M Maahs, Justyna Siwy, Angel Argilés, et al.
Annals of Internal Medicine|January 9, 2023
Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline UpdateSankar D Navaneethan, Sophia Zoungas, M Luiza Caramori, et al.
Gastroenterology|February 27, 2023
Sphingolipids Are Depleted in Alcohol-Related Liver FibrosisMaja Thiele, Tommi Suvitaival, Kajetan Trošt, et al.
The Lancet. Diabetes & Endocrinology|August 7, 2026
Effect of semaglutide on kidney outcomes in the SELECT, FLOW, and SOUL trials: a prespecified pooled analysisJohannes F E Mann, Sunil V Badve, Florian M M Baeres, et al.
Kidney International|July 13, 2020
Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatmentIan H de Boer, M Luiza Caramori, Juliana C N Chan, et al.
Diabetologia|July 30, 2024
Longitudinal metabolite and protein trajectories prior to diabetes mellitus diagnosis in Danish blood donors: a nested case-control studyAgnete T Lundgaard, David Westergaard, Timo Röder, et al.
Annals of Internal Medicine|November 9, 2020
Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice GuidelineSankar D Navaneethan, Sophia Zoungas, M Luiza Caramori, et al.
The Journal of Clinical Endocrinology and Metabolism|April 10, 2020
Plasma Metabolomics Identifies Markers of Impaired Renal Function: A Meta-analysis of 3089 Persons with Type 2 DiabetesNete Tofte, Nicole Vogelzangs, Dennis Mook-Kanamori, et al.
Pageof 71